Vaccines targeting helper T cells for cancer immunotherapy
- 26 July 2017
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Immunology
- Vol. 47, 85-92
- https://doi.org/10.1016/j.coi.2017.07.004
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01 CA178846, P30 CA044579)
This publication has 72 references indexed in Scilit:
- Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletionNature Medicine, 2013
- A Novel Dendritic Cell-based Immunization Approach for the Induction of Durable Th1-polarized Anti-HER-2/neu Responses in Women With Early Breast CancerJournal of Immunotherapy, 2012
- CD4 + T cells support cytotoxic T lymphocyte priming by controlling lymph node inputProceedings of the National Academy of Sciences of the United States of America, 2011
- Interferons Induce CXCR3-cognate Chemokine Production by Human Metastatic MelanomaJournal of Immunotherapy, 2010
- CD4+ T-Cell Help in the Tumor Milieu Is Required for Recruitment and Cytolytic Function of CD8+ T LymphocytesCancer Research, 2010
- Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanomaThe Journal of Experimental Medicine, 2010
- Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hostsThe Journal of Experimental Medicine, 2010
- CD8+ T lymphocyte mobilization to virus-infected tissue requires CD4+ T-cell helpNature, 2009
- Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell RecruitmentCancer Research, 2009
- Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1The New England Journal of Medicine, 2008